• Zimbabwe has made significant investments in hospital infrastructure and equipment under the Presidential Hospital Renovation Programme since 2025
• Poor wages for health workers and chronic medicine shortages in public hospitals remain major obstacles, as evidenced by the 2026 nurses’ strikes and before
• Sustainable improvements in healthcare delivery will depend on guaranteed operational budgets, competitive living wages for health workers, and reliable medicine supply

Harare, Zimbabwe’s public hospital system has received more documented investment commitment between 2025 and mid 2026 than in any comparable recent period, and the gap between what has been invested and what can be confirmed about patient outcomes is now the most important unanswered question in the country’s healthcare reform agenda. The Presidential Hospital Renovation Programme, launched after President Emmerson Mnangagwa conducted surprise inspections of major referral hospitals and found sections in a dilapidated state, has progressed from announcement to physical execution at Zimbabwe’s two largest central hospitals.

Public hospitals are being rebuilt, machines are arriving and new health financing reforms are being drafted, yet the decisive question for patients is still simple. Will a woman in labour find oxytocin at Mbuya Nehanda, will a cancer patient at Parirenyatwa start radiotherapy before the disease advances, and will a nurse at Mpilo stay on duty long enough for the renovated ward to change survival outcomes?

The refurbishment of Adlam House and the Nurses Home at Parirenyatwa Group of Hospitals was commissioned in May 2026, with presidential spokesperson George Charamba publicly acknowledging the pre renovation conditions as reflecting infrastructure decay, policy gaps and systematic overload. Rehabilitation works are also underway at Mpilo Central Hospital in Bulawayo and Sally Mugabe Central Hospital in Harare, while Mbuya Nehanda Maternity Hospital handed over its upgraded maternity wing on 12 May 2026.

Finance Minister Professor Mthuli Ncube, who toured Mpilo in June 2026, confirmed that one of the refurbished hospital blocks is expected to be completed by August 2026 and pledged continued procurement of oncology equipment using Sugar Content Tax proceeds. That commitment is important, but the operational position is more cautious than the procurement announcements suggest. The new cancer equipment has moved through procurement and installation processes, but it is not yet carrying the current treatment load.

The sugar tax equipment is the clearest example of the new health financing model because it connects a domestic tax to a visible clinical bottleneck. Zimbabwe has spent about US$27 million from sugar tax revenues on cancer treatment equipment, with government saying the investment is expected to reduce a cancer treatment backlog of about 800 patients once the equipment becomes operational.

That wording matters. The backlog is not reduced by procurement or installation alone. It falls only when a patient moves from waiting list to treatment, from diagnosis to first session, and from interrupted care to a completed radiotherapy cycle.

A health worker familiar with the oncology equipment rollout, who spoke on condition of anonymity because they are not authorised to comment publicly, said the new cancer machines have been installed but have not yet come into use. “The installation has been done, but the machines are not working yet,” he said. “For now, the old machines are the ones still being used. Maybe when the new machines come into use, they will help decentralise cancer treatment to other facilities, because right now patients are still concentrated at the main referral centres.”

That distinction changes the oncology calculus. The Sugar Content Tax has moved Zimbabwe from financing talk to equipment procurement and installation, but the patient outcome gain begins only when the machines are commissioned, staffed, maintained, supplied with treatment planning systems and backed by reliable consumables. Until then, the public oncology system remains dependent on older working machines, particularly at Parirenyatwa, while Mpilo’s role as a decentralised cancer treatment centre remains a pending capacity shift rather than a confirmed operational reality.

Zimbabwe has more cancer patients than its current functioning public radiotherapy capacity can comfortably absorb. The new machines are therefore necessary, but they remain few relative to demand and are not yet operational according to the nurse interviewed. The public should be told every quarter how many cancer machines are installed, how many are functional, how many patients are waiting, how many start treatment, how many complete treatment and how many sessions are lost to machine downtime, staffing shortages or consumable gaps.

A cancer patient at Parirenyatwa, who requested anonymity because of the sensitivity of their condition said, “the queues are still long,” the patient said. “You have to wait long, but at least you are not turned away simply because you do not have thousands of dollars requested in private clinics.”

The patient’s experience shows why public oncology investment matters, even before the new machines fully come into use. Older public machines are still carrying the current treatment burden, but they are doing so in a system that gives patients an option outside private hospitals. The new equipment will change outcomes only if it expands the number of functioning treatment points, reduces queues and allows patients to complete treatment faster.

The staffing investment announced alongside the infrastructure programme was the largest single workforce commitment in Zimbabwe’s health sector in years. Treasury approved 8,785 new health worker posts for 2026, building on approximately 3,700 workers recruited from the 5,284 posts approved in 2025, with the announcement made by Deputy Finance Minister Kudakwashe Mnangagwa at the Human Resources for Health Dialogue Meeting on 28 May 2026.

A US$11.8 million retention scheme targeting rural health workers through accommodation support and career development programmes was confirmed at the same forum, with government committing approximately US$1.67 billion toward a Health Workforce Investment Compact over three years, targeting a doubling of the health workforce by 2030 and a 50% reduction in attrition.

The Global Fund allocated US$412.9 million for the 2026 to 2028 period to combat HIV, tuberculosis and malaria while strengthening health systems broadly, and between 2021 and 2025 Government constructed 200 new health facilities, bringing Zimbabwe’s total public health institutions to 1,953, with more than 1,000 facilities having received solar energy backup power under the Solar for Health programme by 2022.

The investment is real and physically visible. The missing evidence is clinical. Zimbabwe can confirm renovated blocks, new machines, staff posts, solar systems and donor support, but it has not yet published systematic before and after patient outcome data from the hospitals receiving the largest investments. That gap is not a technical omission, it is the central accountability question in the hospital renovation programme.

The national health budget of approximately US$800 million, equivalent to around US$50 per capita, with 80% absorbed by the maintenance and operation of about 100 major hospitals and 1,600 health clinics, remains below the 15% Abuja Declaration target, with the 2026 allocation standing at 10% using analytical benchmarks even as Government presents a 15% figure using the official pegged exchange rate.

Health Minister Dr Douglas Mombeshora acknowledged at the launch of the National Health Strategy 2026 to 2030 that many public health facilities receive less than 50% of their allocated operational budgets, and that out of pocket payments by households, which stood at 27.8% in 2023, continue to expose families to catastrophic health expenditures. These are structural conditions that physical renovation and new equipment alone cannot resolve, and whose persistence means that the patient outcome improvements promised by the renovation programme remain conditional on operational budget adequacy.

The most instructive confirmed patient outcome dataset available for Zimbabwe’s public hospital system comes from Mpilo Central Hospital’s own published research, covering a period that predates the current renovation programme but establishes the baseline against which future improvements must be measured.

A peer reviewed study published in 2022 in the Journal of Perinatal Medicine documented that Mpilo’s maternal mortality ratio declined from 655 per 100,000 live births in 2011 to 203 per 100,000 by 2020, a 69% reduction achieved through leadership, accountability and clinical protocol improvements in a low resource setting whose physical infrastructure had not materially changed. The lead causes of maternal mortality across the decade were hypertensive disorders, obstetric haemorrhage, pregnancy related infection and pregnancies with abortive outcomes, each of which responds to clinical intervention rather than infrastructure quality alone.

That a hospital whose walls were deteriorating and whose equipment budgets were chronically underfunded could reduce its maternal mortality ratio by 69% through clinical discipline and protocol adherence is simultaneously a tribute to Mpilo’s clinical leadership and an indictment of the assumption that infrastructure investment is the primary determinant of patient outcomes.

The 280 child deaths recorded at Mpilo over four months in 2024 amid severe resource shortages confirmed that the resource floor below which clinical discipline cannot compensate for physical inadequacy had been reached and breached.

While the new equipment and renovations address infrastructure gaps, improved outcomes hinge on sustained funding for operations, adequate staffing and reliable procurement of medicines. These are the same inputs that supported clinical protocols and drove a 69% reduction in maternal mortality between 2011 and 2020.

Parirenyatwa Group of Hospitals, Zimbabwe’s largest referral facility with 1,800 beds and a workforce of more than 2,000, presents a parallel case. The hospital’s dialysis capacity constraint, with 50% of dialysis machines out of service in documented reports, compromised care for approximately 130 critically ill kidney patients, and the renovation programme’s commitment to new beds, theatre tools, X ray equipment and CT scan technology addresses gaps whose clinical consequences were measurable in treatment delays and referral volumes.

Parirenyatwa should now be treated as the machine availability test case. The hospital’s size means a single equipment failure affects national referral capacity. The minimum public dashboard should show how many dialysis machines are installed, how many are functional, how many patients are booked weekly and how many sessions are missed because of machine downtime, consumables or staffing.

Those figures would show whether the renovation programme is restoring actual treatment capacity or replacing visible infrastructure without resolving service interruption.

The e learning platform introduced at Mpilo’s School of Midwifery in 2024, championed by Principal Tutor Kushupika Dube, represents a lower cost intervention whose effect on clinical competency does not require physical renovation to deliver improvement. It allows students to review practical procedures before clinical practice and addresses the knowledge transfer gap that resource constrained training environments consistently produce.

What the SADC Region Shows Zimbabwe

The regional comparison that Zimbabwe’s renovation programme must withstand reveals both how far the country has come and how far its structural architecture remains from what sustained health system performance requires. Zambia’s maternal mortality ratio reached 85 per 100,000 live births in 2023, a figure that compares with Zimbabwe’s most recently confirmed national maternal mortality rate of approximately 357 per 100,000, placing Zambia materially ahead of Zimbabwe on the indicator that most directly measures the quality of obstetric care available to women at the moment of greatest clinical vulnerability.

Zambia maintains more than 2,900 public health facilities, including 1,839 health centres and 953 health posts, against Zimbabwe’s 1,953 public health institutions, despite a comparable population, and in December 2025 Zambia signed a National Health Compact with the World Bank committing to recruit 74,000 health workers and expand primary care over five years.

This is a structured, externally accountable workforce commitment whose scale and conditionality differ from Zimbabwe’s internally announced staffing targets.

Zambia’s actual health budget share recorded 11.8% and 10.4% in 2023 and 2024 respectively, both below the Abuja Declaration’s 15% target but above Zimbabwe’s confirmed analytical allocation. In Eastern Province alone, electronic health record coverage reached 61% of more than 420 facilities as of 2025, a provincial digitisation rate whose specificity is the kind of granular, verifiable progress measure that Zimbabwe’s health reporting does not yet consistently produce.

South Africa’s trajectory is the most instructive benchmark for Zimbabwe’s structural ambitions, both as a cautionary illustration of what legal and political complexity can do to a universal health coverage vision and as evidence that the resources Zimbabwe lacks are not the only constraint on health system transformation. South Africa’s National Health Insurance became law in May 2024 when President Cyril Ramaphosa signed it, committing the country to a phased universal coverage rollout, but by February 2026 Ramaphosa had agreed to delay proclamation or implementation of sections of the NHI Act until the Constitutional Court rules on legal challenges.

In the 2024 to 2025 financial year, South Africa substantially revitalised 47 existing clinics and community health centres and 45 hospitals, while maintaining, repairing or refurbishing 403 public health facilities, and is currently constructing the country’s 11th central academic hospital in Limpopo alongside multiple new district facilities across the Eastern Cape and Free State. South Africa spends approximately US$580 per capita on health, about eleven times Zimbabwe’s US$50 per capita, and its private sector, which serves approximately 16% of the population, absorbs nearly half of total national health spending, creating the two speed healthcare dynamic whose inequity the NHI is designed to address.

Zimbabwe’s Medical Services Amendment Act of 2026 now pulls private hospitals into the emergency access architecture by requiring health institutions to admit patients with life threatening emergency conditions and keep them for at least 48 hours for stabilisation before transfer or cost recovery is resolved. This is not a general free treatment model for all patients, but an emergency stabilisation obligation.

Its importance is that the first 48 hours determine survival in trauma, obstetric emergencies, acute cardiac events, severe respiratory distress and sepsis. Its risk is that the law creates clinical obligations before the reimbursement mechanism has been proven at scale.

The Human Resource Reality

While Treasury approved thousands of new health worker posts in 2025 and 2026, the recruitment drive risks being undermined by poor remuneration.

Another female health worker at Parirenyatwa Group of Hospitals, speaking on condition of anonymity, said hiring more nurses and doctors without improving wages and living standards will not produce lasting gains. “Competitive salaries, comparable to those in the region, are essential to retain skilled staff and reduce the risk of strikes that disrupt services,” the worker said.

Improving infrastructure and hiring more nurses will deliver limited results if living conditions and wages are not addressed. Unlike South Africa and Zambia, where governments have periodically adjusted health worker salaries to retain staff, Zimbabwe has not implemented a sustainable wage improvement framework. Without competitive and livable wages, the risk of industrial action remains high, as seen in 2026 when nurses at Parirenyatwa and Sally Mugabe Central Hospitals downed tools over poor pay and working conditions. A motivated and stable workforce is as critical as new buildings and machines.

The Medicine Gap

A second critical weakness is the persistent shortage of essential medicines in public hospitals.

A medical doctor at Sally Mugabe Central Hospital who refused to be reviewd by the name said the gap between public and private sector medicine access must be closed if the renovation programme is to change outcomes.

“Reliable supply of essential medicines in public facilities would reduce the financial burden on households and improve treatment adherence,” he said.

Many patients who visit public facilities are still forced to buy drugs from private pharmacies at significantly higher prices. This creates a two tier reality where access to treatment depends on a patient’s ability to pay out of pocket, contradicting the goal of equitable healthcare.

A patient treated at a public hospital for a chronic condition, who also requested anonymity because of the sensitivity of their medical situation, said consultations in the public system remain affordable, but medicine shortages still push patients into costly private pharmacies.

“The doctor attended to me at the hospital, but some of the medicines were not available,” the patient said. “I had to go outside and buy from a private pharmacy, and that is where the cost becomes difficult. The consultation may be manageable, but if the medicine is not there, the burden comes back to the patient.”

The patient said the cost of buying medicines privately can delay treatment for households without immediate cash.

“Sometimes you do not buy everything at once because you do not have enough money,” the patient said. “You buy what you can afford first and hope to get the rest later. That affects how you follow the treatment because the doctor gives you a plan, but the pharmacy cost decides whether you complete it.”

The medicine supply chain remains unreliable in most public hospitals, with facilities frequently reporting stock outs of basic antibiotics, antihypertensives and other essential drugs. Until this gap is closed through consistent procurement and supply chain reforms, new infrastructure and diagnostic equipment will have limited impact on actual health outcomes.

What Government Must Do

The investment made in 2025 and 2026 provides the physical foundation. What converts bricks and machines into measurable patient outcome improvements is a set of policy decisions that the renovation programme has not yet fully made. The first and most consequential is the operational budget guarantee, a ring fenced operational allocation to each renovated facility, confirmed and disbursed at the beginning of each financial quarter rather than subject to the less than 50% delivery rate that Minister Mombeshora acknowledged, so that the CT scanner at Parirenyatwa has reagents, the theatre at Mpilo has anaesthetic consumables and the maternity ward at Mbuya Nehanda has oxytocin.

A machine without consumables is a renovation photograph, while a consumable budget without a machine is an incomplete investment. Both must arrive together for the clinical outcome to change.

The second is a systematic outcomes monitoring framework whose publication is mandatory and quarterly. Zimbabwe’s National Health Strategy 2026 to 2030 sets targets including life expectancy of 70 years, reductions in maternal and under five mortality, and a universal health service coverage index of 80 by 2030 against the current 55.

None of those targets is verifiable without facility level outcome data published by institution, by indicator and by time period, and none is improvable without a management accountability structure that connects individual hospital leadership performance to measured patient outcomes rather than to input delivery alone. Zambia’s use of the District Health Information Software DHIS2, which captures maternal and child health data at facility level across the country in real time, is the minimum architecture whose adoption in Zimbabwe would convert the National Health Strategy’s targets from aspirations into monitored commitments.

Zimbabwe’s own Impilo electronic health record system had been deployed at 1,178 facilities as of late 2024, and Parirenyatwa is among the central hospitals included in that rollout. The gap is not absence of the system, but usage. Impilo is not yet fully integrated with the national DHIS2 reporting structure, and facility level outcome data is not published quarterly by hospital. Prioritising that technical connection would produce the before and after patient outcome data that the renovation programme currently cannot provide.

The National Health Insurance Bill, currently before Parliament, must now deliver the health financing architecture that connects new infrastructure to actual patient access. Zimbabwe’s 27.8% out of pocket payment share is more than twice what South African households contribute despite that country’s own financing inequities, and every percentage point of that burden represents families delaying care because they cannot afford consultation, transport, medicine or private pharmacy costs.

A functioning National Health Insurance scheme, financed through earmarked contributions on a model similar to the AIDS levy that has sustained Zimbabwe’s HIV response across three decades of fiscal volatility, would provide the predictable, ring fenced revenue stream whose absence is the single most important structural constraint on the renovation programme’s ability to deliver its clinical promise.

Zimbabwe has been working toward an NHI model intended to reduce out of pocket costs and expand coverage to the uninsured majority.

The Sugar Content Tax model confirms that ring fenced health financing is politically achievable in Zimbabwe when the revenue source and the expenditure purpose are directly connected in public communication. It has already funded cancer equipment procurement and installation, although the latest interview evidence shows that installation has not yet translated into routine patient treatment through the new machines.

That is the difference between health financing success at Treasury level and health outcome success at ward level.

The NHI Bill must make that connection explicit, sustainable and institutionally protected from the budget discretion that has historically delivered public health facilities less than half of what they were allocated.

The National Health Strategy 2026 to 2030 targets an increase in life expectancy from 64.7 years to 70 years, and life expectancy has already risen to 65 years as a result of improvements that predate the current renovation programme. The universal health service coverage index of 55 out of 100, against a target of 80 by 2030, is the summary measure whose movement over the next five years will determine whether the investment commitment of 2025 and 2026 translates into confirmed patient outcome improvements or joins the list of healthcare plans whose targets exceeded their implementation.

Physical investment has moved. Construction continues, equipment has been procured and installed in parts, 8,785 staffing posts have been approved for 2026, emergency obligations have been placed on private hospitals, and the National Health Insurance Bill is advancing. What has not moved are the systems that make it work. As of mid-2026, government still has to: 1. Ring-fence operational funding for renovated facilities. 2. Publish a public oncology dashboard tracking installation and patient use of cancer machines. 3. Release quarterly, hospital-level outcome data. 4. Finalise a sustainable health financing architecture. Those four decisions will determine the programme’s legacy.

It is these, not the bricks alone, that will define the programme’s legacy.

Equity Axis News